[HTML][HTML] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - The Lancet infectious …, 2021 - thelancet.com
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
[PDF][PDF] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu, W Han… - 2020 - sostelemedicina.ucv.ve
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - The Lancet Infectious …, 2021 - thelancet.com
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
[HTML][HTML] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - The Lancet. Infectious …, 2021 - ncbi.nlm.nih.gov
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
[PDF][PDF] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu, W Han… - 2020 - static.poder360.com.br
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - The Lancet. Infectious …, 2020 - europepmc.org
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
[PDF][PDF] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - Lancet Infect …, 2021 - centromedicoabc.com
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - The Lancet Infectious …, 2021 - Elsevier
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu, W Han… - 2020 - cabidigitallibrary.org
Background: With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled …
Y Zhang, G Zeng, H Pan, C Li, Y Hu… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …